Simple jQuery Dropdowns
Please use this identifier to cite or link to this item:
Title: Highlights of the 2019 Japanese Society of Hypertension Guidelines and perspectives on the management of Asian hypertensive patients
Authors: Satoshi Hoshide
Kazuomi Kario
Naoko Tomitani
Tomoyuki Kabutoya
Yook Chin Chia
Sungha Park
Jinho Shin
Yuda Turana
Jam Chin Tay
Peera Buranakitjaroen
Chen Huan Chen
Jennifer Nailes
Huynh Van Minh
Saulat Siddique
Jorge Sison
Arieska Ann Soenarta
Guru Prasad Sogunuru
Apichard Sukonthasarn
Boon Wee Teo
Narsingh Verma
Yuqing Zhang
Tzung Dau Wang
Ji Guang Wang
University Medicine and Pharmacy, Hue University
De La Salle Health Sciences Institute
Sunway University
Hanyang University Medical Center
Jichi Medical University
Yonsei University Health System
Shanghai Jiao Tong University School of Medicine
Madras Institute of Orthopaedics and Traumatology Hospitals
National Taiwan University Hospital
Kathmandu University
University of the East Ramon Magsaysay Memorial Medical Center
Fatima Memorial Hospital
National Yang-Ming University Taiwan
Universitas Katolik Indonesia Atma Jaya
Universitas Indonesia
University of Malaya
Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
Yong Loo Lin School of Medicine
King George's Medical University
Faculty of Medicine, Siriraj Hospital, Mahidol University
Tan Tock Seng Hospital
Bangkok Hospital Chiang Mai
Keywords: Medicine
Issue Date: 1-Mar-2020
Citation: Journal of Clinical Hypertension. Vol.22, No.3 (2020), 369-377
Abstract: © 2019 Wiley Periodicals, Inc. Unlike other international guidelines but in accord with the earlier Japanese Society of Hypertension (JSH) guidelines, the 2019 JSH guidelines (“JSH 2019”) continue to emphasize the importance of out-of-office blood pressure (BP) measurements obtained with a home BP device. Another unique characteristic of JSH 2019 is that it sets clinical questions about the management of hypertension that are based on systematic reviews of updated evidence. JSH 2019 states that individuals with office BP < 140/90 mm Hg do not have normal BP. The final decisions regarding the diagnosis and treatment of hypertension should be performed based on out-of-office BP values together with office BP measurements. For hypertensive adults with comorbidities, the office BP goal is usually <130/80 mm Hg and the home BP goal is <125/75 mm Hg. Recommendations of JSH 2019 would be valuable for not only Japanese hypertensive patients but also Asian hypertensive patients, who share the same features including higher incidence of stroke compared with that of myocardial infarction and a steeper blood pressure-vascular event relationship.
ISSN: 17517176
Appears in Collections:Scopus 2020

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.